BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Seltorexant readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Seltorexant\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06559306-802@assetmemo.bio
DTSTAMP:20261121T005640Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:Seltorexant: Phase 3 readout est. (NCT06559306)
DESCRIPTION:Seltorexant\, phase 3\, Major Depressive Disorder.\nStudy: Phas
 e 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Pa
 rticipants With Major Depressive Disorder and Insomnia Symptoms\nEstimated
  primary completion: 30 December 2026. This is a ClinicalTrials.gov estima
 te\, not a confirmed readout date\, and it can move.\nDrug page: https://a
 ssetmemo.bio/drug/seltorexant#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT06559306
URL:https://assetmemo.bio/drug/seltorexant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07573176-802@assetmemo.bio
DTSTAMP:20261121T005640Z
DTSTART;VALUE=DATE:20280824
DTEND;VALUE=DATE:20280825
SUMMARY:Seltorexant: Phase 3 readout est. (NCT07573176)
DESCRIPTION:Seltorexant\, phase 3\, Major Depressive Disorder.\nStudy: A St
 udy of Seltorexant as Monotherapy in Adults and Elderly Participants With 
 Major Depressive Disorder\nEstimated primary completion: 24 August 2028. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/seltorexant#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07573176
URL:https://assetmemo.bio/drug/seltorexant#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
